Presence of cytosis according to JAK2V617F mutation status and MPN diagnosis
| . | Patients with JAK2V617F with MPN n = 9 . | Patients with JAK2V617F without MPN n = 52 . | Patients without JAK2V617F n = 477 . |
|---|---|---|---|
| Erythrocytosis∗, n (%) | 3 (33.3) | 8 (15.4) | 58 (13.2) |
| Thrombocytosis†, n (%) | 6 (66.7) | 2 (3.9) | 22 (4.7) |
| Leukocytosis‡, n (%) | 6 (66.7) | 21 (40.4) | 187 (39.5) |
| Any cytosis, n (%) | 8 (88.9) | 25 (48.1) | 223 (49.3) |
| . | Patients with JAK2V617F with MPN n = 9 . | Patients with JAK2V617F without MPN n = 52 . | Patients without JAK2V617F n = 477 . |
|---|---|---|---|
| Erythrocytosis∗, n (%) | 3 (33.3) | 8 (15.4) | 58 (13.2) |
| Thrombocytosis†, n (%) | 6 (66.7) | 2 (3.9) | 22 (4.7) |
| Leukocytosis‡, n (%) | 6 (66.7) | 21 (40.4) | 187 (39.5) |
| Any cytosis, n (%) | 8 (88.9) | 25 (48.1) | 223 (49.3) |